Evidence map›Paper›PMID 26260456›Full record

ArticleJournal of bacteriology2015

Loss of Antibiotic Tolerance in Sod-Deficient Mutants Is Dependent on the Energy Source and Arginine Catabolism in Enterococci.

Rabia Ladjouzi, Alain Bizzini, Willem van Schaik, Xinglin Zhang, Alain Rincé, Abdellah Benachour, Axel Hartke

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bacteriology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. c-di-AMP Is Essential for the Virulence ofInfection and immunity · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Sublethal Paraquat Confers Multidrug Tolerance inFrontiers in microbiology · 2020
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Rabia LadjouziUniversité de Caen Basse-Normandie, EA4655 U2RM-Stress et Virulence, Caen, France Université de Bejaia, FSNV, Laboratoire d'Ecologie Microbienne, Bejaia, Algeria.
Alain BizziniUniversité de Caen Basse-Normandie, EA4655 U2RM-Stress et Virulence, Caen, France.
Willem van SchaikDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Xinglin ZhangDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Alain RincéUniversité de Caen Basse-Normandie, EA4655 U2RM-Stress et Virulence, Caen, France.
Abdellah BenachourUniversité de Caen Basse-Normandie, EA4655 U2RM-Stress et Virulence, Caen, France.
Axel HartkeUniversité de Caen Basse-Normandie, EA4655 U2RM-Stress et Virulence, Caen, France axel.hartke@unicaen.fr.
Université de Caen Normandie · FRUniversity Medical Center Utrecht · NLUniversity of Béjaïa · DZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledEnterococci are naturally tolerant to typically bactericidal cell wall-active antibiotics, meaning that their growth is inhibited but they are not killed even when exposed to a high concentration of the drug. The molecular reasons for this extraordinary tolerance are still incompletely understood. Previous work showed that resistance to killing collapsed specifically in mutants affected in superoxide dismutase (Sod) activity, arguing that bactericidal antibiotic treatment led to induction of a superoxide burst. In the present work, we show that loss of antibiotic tolerance in ΔsodA mutants of pathogenic enterococci is dependent on the energy source present during antibiotic treatment. Hexoses induce greater killing than the pentose ribose, and no killing was observed with glycerol as the energy source. These results point to glycolytic reactions as crucial for antibiotic-mediated killing of ΔsodA mutants. A transposon mutant library was constructed in Enterococcus faecalis ΔsodA mutants and screened for restored tolerance of vancomycin. Partially restored tolerance was observed in mutants with transposon integrations into intergenic regions upstream of regulators implicated in arginine catabolism. In these mutants, the arginine deiminase operon was highly upregulated. A model for the action of cell wall-active antibiotics in tolerant and nontolerant bacteria is proposed. IMPORTANCE: Antibiotic tolerance is a serious clinical concern, since tolerant bacteria have considerably increased abilities to resist killing by bactericidal drugs. Using enterococci as models for highly antibiotic-tolerant pathogens, we showed that tolerance of these bacteria is linked to their superoxide dismutase (Sod), arguing that bactericidal antibiotics induce generation of reactive oxygen species inside cells. Wild-type strains are tolerant because they detoxify these deleterious molecules by the activity of Sod, whereas Sod-deficient strains are killed. This study showed that killing depends on the energy source present during treatment and that an increase in arginine catabolism partially restored tolerance of the Sod mutants. These results are used to propose a mode-of-action model of cell wall-active antibiotics in tolerant and nontolerant bacteria.

Indexed as

Anti-Bacterial AgentsArginineCarbohydrate MetabolismDNA Transposable ElementsDrug Resistance, BacterialEnterococcus faecalisGene Expression Regulation, BacterialGene Expression Regulation, EnzymologicMicrobial Sensitivity TestsMutagenesis, InsertionalMutationPenicillinsSuperoxide DismutaseVancomycinAnti-Bacterial AgentsArginineDNA Transposable ElementsPenicillinsSuperoxide DismutaseVancomycin

Identifiers

PMID26260456
PMCPMC4573725
OpenAlexW1946295703

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.